Fig. 1From: Development and validation of a model that includes two ultrasound parameters and the plasma D-dimer level for predicting malignancy in adnexal masses: an observational studyFlow diagram shows the inclusion and exclusion of eligible patients. BOT borderline malignant ovarian tumor, CA-125 cancer antigen 125, EOC epithelial ovarian cancer, US ultrasoundBack to article page